SCHEDULE: Beretta Holding S.A. Amends Ruger Stake, Eyes Strategic Options

Beretta Holding S.A. has filed an amended Schedule 13D, confirming its 9.95% stake in Sturm, Ruger & Company, Inc. and signaling a potential pursuit of strategic alternatives, including board representation.

Summary

• Beretta Holding S.A. (the "Reporting Person") filed Amendment No. 2 to its Schedule 13D regarding its investment in Sturm, Ruger & Company, Inc.
• The Reporting Person beneficially owns 1,587,000 shares of Sturm, Ruger & Company, Inc. Common Stock.
• This represents 9.95% of the Issuer's outstanding common stock, based on approximately 15,944,253 shares outstanding as of October 17, 2025.
• The aggregate purchase price for these shares is approximately $60.3 million, including brokerage commissions, funded by working capital.
• Beretta Holding S.A. views the shares as an attractive investment opportunity within the industry.
• Beretta Holding S.A. is actively evaluating a wide range of strategic alternatives for its investment in Sturm, Ruger & Company, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant strategic move by a major industry player, Beretta Holding S.A., into Sturm, Ruger & Company, Inc. The stated intent to explore strategic alternatives, including board representation, suggests potential for value creation or significant corporate action. However, the presence of a poison pill by Sturm, Ruger introduces a potential hurdle, balancing the positive outlook with potential conflict.

Positives

• Beretta Holding S.A. views Sturm, Ruger & Company, Inc. as an attractive investment opportunity within the industry.
• The significant stake of 9.95% indicates strong conviction from a major industry player.
• The stated intent to pursue strategic alternatives could unlock shareholder value for Sturm, Ruger & Company, Inc.

Negatives

• Sturm, Ruger & Company, Inc. adopted a stockholder rights plan (poison pill) effective October 14, 2025, which could complicate Beretta Holding S.A.'s strategic actions.
• The potential for activist engagement may lead to management distraction or conflict within Sturm, Ruger & Company, Inc.

Risks

• Sturm, Ruger & Company, Inc.'s stockholder rights plan (poison pill) could limit Beretta Holding S.A.'s ability to acquire additional shares or pursue certain strategic alternatives without board approval.
• Market conditions, industry conditions, and regulatory considerations could impact the success of Beretta Holding S.A.'s investment objectives.
• There is potential for conflict with current management or the board of Sturm, Ruger & Company, Inc. if Beretta Holding S.A. pursues board representation or significant strategic changes.

Future Outlook

Beretta Holding S.A. intends to review its investment in Sturm, Ruger & Company, Inc. on an ongoing basis and may formulate, revise, or withdraw plans and proposals at any time. Beretta Holding S.A. is actively evaluating a wide range of strategic alternatives, including acquiring more shares, disposing of holdings, seeking board representation, proposing extraordinary corporate transactions, advocating for changes in strategy or governance, and engaging with third parties.

Management Comments

• Beretta Holding S.A. acquired the shares of Sturm, Ruger & Company, Inc. based on its belief that the shares represent an attractive investment opportunity within the industry.
• Beretta Holding S.A. is actively evaluating a wide range of strategic alternatives with respect to its investment in Sturm, Ruger & Company, Inc.

Industry Context

This filing highlights potential consolidation or activist interest within the firearms manufacturing industry. Beretta Holding S.A., a major global player, has taken a significant stake in Sturm, Ruger & Company, Inc., another prominent firearms manufacturer. Beretta's stated intent to explore strategic alternatives could signal a shift in competitive dynamics or a move towards industry consolidation. The adoption of a "Rights Plan" (poison pill) by Sturm, Ruger & Company, Inc. suggests the target company is aware of and potentially resistant to an unsolicited takeover or significant influence from Beretta.

Comparison to Industry Standards

• The 9.95% stake held by Beretta Holding S.A. is a substantial minority position, often a threshold for significant influence or activist engagement in publicly traded companies.
• The adoption of a stockholder rights plan by Sturm, Ruger & Company, Inc. is a common defensive tactic employed by boards to deter hostile takeovers or limit the accumulation of large stakes by activist investors, similar to actions seen in other industries facing activist pressure.
• Beretta Holding S.A.'s stated intent to seek board representation or propose strategic changes aligns with typical activist investor playbooks observed across various sectors.

Corporate Governance

Stakeholder Impact

• Shareholders (Sturm, Ruger): Potential for increased shareholder value if Beretta's strategic initiatives are successful, but also potential for uncertainty or conflict if a proxy battle ensues. The poison pill could limit premium offers.
• Management (Sturm, Ruger): May face pressure from Beretta Holding S.A. regarding strategy, operations, or board composition.
• Employees (Sturm, Ruger): Potential for changes in corporate strategy or structure could impact employees, depending on the outcome of Beretta's actions.
• Competitors: Increased M&A activity or activist engagement in the firearms industry could prompt other players to re-evaluate their strategies.

Next Steps

• Beretta Holding S.A. will continue to review its investment in Sturm, Ruger & Company, Inc.
• Beretta Holding S.A. may acquire additional shares or other securities of Sturm, Ruger & Company, Inc.
• Beretta Holding S.A. may dispose of some or all of its holdings in Sturm, Ruger & Company, Inc.
• Beretta Holding S.A. may seek representation on Sturm, Ruger & Company, Inc.'s board of directors.
• Beretta Holding S.A. may propose or engage in discussions regarding strategic alternatives, extraordinary corporate transactions, or potential business combination/change-of-control transactions.
• Beretta Holding S.A. may propose or advocate changes to Sturm, Ruger & Company, Inc.'s strategy, operations, capital allocation, governance, management, or corporate structure.
• Beretta Holding S.A. may engage with third parties (including other stockholders, potential partners, financing sources, or counterparties).
• Beretta Holding S.A. may request a special meeting of stockholders or take action by written consent.
• Beretta Holding S.A. may enter into various customary arrangements (confidentiality, advisory, financing, swap, derivative) in connection with its objectives.

Key Dates

Recommendation

Beretta Holding S.A.'s significant stake and stated intent to explore strategic alternatives, including potential board representation or corporate transactions, introduces both upside potential and uncertainty for Sturm, Ruger & Company, Inc. shareholders. The adoption of a poison pill by Sturm, Ruger indicates potential resistance, which could lead to a prolonged engagement or conflict. While the prospect of value creation exists, the immediate future involves strategic maneuvering and potential volatility. A "hold" recommendation allows investors to observe how these strategic discussions and potential actions unfold without taking an immediate directional bet, given the balanced risks and opportunities.

Keywords

Sturm Ruger, Beretta Holding, Schedule 13D, activist investor, firearms industry, common stock, strategic alternatives, corporate governance, investment, shareholder rights plan